Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, PUSP-RP
Subjects: ANTINEOPLÁSICOS, APOPTOSE, LINHAGEM CELULAR, LIGANTES, NEOPLASIAS OVARIANAS
ABNT
POSSATO, Bruna et al. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets. European Journal of Pharmaceutical Sciences, v. 162, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105834. Acesso em: 26 ago. 2024.APA
Possato, B., Dalmolin, L. F., Pereira, L. M., Alves, J. Q., Silva, R. T. C., Gelamo, R. V., et al. (2021). Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets. European Journal of Pharmaceutical Sciences, 162. doi:10.1016/j.ejps.2021.105834NLM
Possato B, Dalmolin LF, Pereira LM, Alves JQ, Silva RTC, Gelamo RV, Yatsuda AP, Lopez RFV, Albuquerque S de, Leite NB, Maia PI da S. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 162[citado 2024 ago. 26 ] Available from: https://doi.org/10.1016/j.ejps.2021.105834Vancouver
Possato B, Dalmolin LF, Pereira LM, Alves JQ, Silva RTC, Gelamo RV, Yatsuda AP, Lopez RFV, Albuquerque S de, Leite NB, Maia PI da S. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 162[citado 2024 ago. 26 ] Available from: https://doi.org/10.1016/j.ejps.2021.105834